Sotorasib plus Panitumumab in KRAS-Mutated Colorectal Cancer | NEJM

In patients with metastatic colorectal cancer with KRAS G12C mutation, combining a KRAS G12C inhibitor with an EGFR inhibitor may be an effective strategy.
New research findings are summarized in a short video.
To see the full article, follow this link: nej.md/3M8Qw3k
#colorectalcancer #oncology #cancer